Dosage and administration
Usual adult dose is 1 capsule once or twice daily or as prescribed by a licensed medical practitioner.
ZELAC
- Manufacturer
- Foxland Pharmaceuticals, Inc. | Formulation Technology Incorporated
- Effective date
- 2023-02-20
- Label type
- DIETARY SUPPLEMENT
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:50:40
Label at a glance#
ProductZELAC Probiotic Support
Active ingredientLACTOBACILLUS ACIDOPHILUS, BIFIDOBACTERIUM ANIMALIS LACTIS
Label structure7 sections
Storage and handling
Store at 20°-25°C (68° -77°F); excursions permitted to 15°-30°C (59°- 86°F) [See USP Controlled Room Temperature]. Protect from heat, light and moisture.
Label contents#
Full prescribing information#
STATEMENT OF IDENTITY SECTION
Description
ZELAC capsules is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required, and maintenance of good health is needed.
Warnings and Precautions
ZELAC capsules should only be used under the directions and supervision of a licensed medical practitioner.
Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking other medications.
KEEP OUT OF REACH OF CHILDREN
Dosage and Administration
Usual adult dose is 1 capsule once or twice daily or as prescribed by a licensed medical practitioner.
Precautions
Tamper Evident: Do not use if seal is broken or missing.
Dispensed by Prescription
Storage and Handling
Store at 20°-25°C (68° -77°F); excursions permitted to 15°-30°C (59°- 86°F) [See USP Controlled Room Temperature].
Protect from heat, light and moisture.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Add image transcription here...
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2166201 | Bifidobacterium animalis 7.5 Billion UNT / Lactobacillus acidophilus 8 Billion UNT Oral Capsule | PSN | 2 |
| 2166201 | Bifidobacterium animalis 7500000000 UNT / Lactobacillus acidophilus 8000000000 UNT Oral Capsule | SCD | 2 |
| 2166201 | Bifidobacterium animalis 7.5 Billion UNT / Lactobacillus acidophilus 8 Billion UNT Oral Capsule | SY | 2 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69067-070-30 | ZELAC Probiotic Support | 30 in 1 BOTTLE | CAPSULE | 30 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69067-070-30 | EA - Each | 69067-070 | d9faabb9-f685-4cba-a29d-d70248d83537 | 1 | 2019-06-19 |
Products#
Every source-derived product name is available through these pages.
- ZELAC Probiotic Support
- LACTOBACILLUS ACIDOPHILUS and BIFIDOBACTERIUM ANIMALIS LACTIS
- LACTOBACILLUS ACIDOPHILUS
- BIFIDOBACTERIUM ANIMALIS LACTIS
- GELATIN, UNSPECIFIED
- MICROCRYSTALLINE CELLULOSE
- MALTODEXTRIN
- MAGNESIUM STEARATE
- SILICON DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69067-070 | 69067-070-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOBACILLUS ACIDOPHILUS | 1PRR1V42V5 | ACTIB |
| BIFIDOBACTERIUM ANIMALIS LACTIS | 5307V7XW8I | ACTIB |
| GELATIN, UNSPECIFIED | 2G86QN327L | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
Source Document#
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.